(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the positive outcome of its ...

Investigator & Co-Director of the Neurotherapeutics IWI, Lundquist Institute (Formerly "LA BioMed"); Assistant Professor, David Geffen School of Medicine at UCLA Department of Neurology Ataxia ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today provided an update on ...

Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...

Quince Therapeutics (QNCX) “announced the positive outcome of its pre-planned safety analysis conducted by an independent data and safety ...

Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, said, “Quince remains on track to report topline results for our ...

FDA Established April 23, 2026 as PDUFA Target Date for Review of Submission Seeking Approval for GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) ...

Investigators who designed a base-editing treatment are planning an "umbrella of umbrellas" trial, while others are developing roadmaps to guide personalized treatments.

Get the latest analysis on Iovance Biotherapeutics (IOVA): dilution risks, missed revenue, and margin outlook. Click here to ...

Chime® , a leading consumer financial technology company, announced today that CFO Matt Newcomb will participate in a fireside chat at the UBS Global Technology and AI Conference in Scottsdale, AZ on ...

The College of Healthcare Information Management Executives (CHIME) has recognized PIH Health and PIH Health Physicians as 2025 Digital Health Most Wired recipients. The Digital Health Most Wired ...

Friedreich ataxia is an autosomal-recessive, neurodegenerative disease that primarily affects the nervous system and heart. It was named after Nicolaus Friedreich, a Professor of Medicine in ...